Gladstone Institutional Advisory’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,622
Closed -$56K 741
2021
Q4
$56K Buy
11,622
+500
+4% +$2.02K ﹤0.01% 588
2021
Q3
$41K Hold
11,122
﹤0.01% 536
2021
Q2
$45K Hold
11,122
0.01% 510
2021
Q1
$48K Hold
11,122
0.01% 412
2020
Q4
$44K Hold
11,122
0.01% 294
2020
Q3
$41K Hold
11,122
0.01% 266
2020
Q2
$38K Hold
11,122
0.01% 237
2020
Q1
$15K Hold
11,122
﹤0.01% 265
2019
Q4
$16K Hold
11,122
﹤0.01% 272
2019
Q3
$23K Buy
+11,122
New +$22.7K 0.01% 280

Other funds holding OPK

Gladstone Institutional Advisory's OPK Position: Q1 2022 in Review

Gladstone Institutional Advisory sold out of Opko Health (OPK) in Q1 2022, closing a stake of 11,622 shares — an estimated $56K sold.

Gladstone Institutional Advisory first reported a position in OPK in Q3 2019 and held it in 10 quarters. The position peaked at $56K in Q4 2021. 229 funds tracked by Wall St. Rank hold OPK as of Q1 2022.

  • Gladstone Institutional Advisory reported no remaining Opko Health position as of Q1 2022 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 11,622 Opko Health shares in Q1 2022, an estimated $56K.
  • Gladstone Institutional Advisory first reported a position in Opko Health in Q3 2019 and held it in 10 quarters.
  • Gladstone Institutional Advisory's Opko Health position peaked at $56K in Q4 2021.
  • 229 funds tracked by Wall St. Rank held Opko Health as of Q1 2022.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2022, filed 4 May 2022.